MXPA06012870A - Acido 2-{[2-(2- metilaminopirimidin -4-il)-1h- indol-5 -carbonil]amino}-3 -(fenilpiridin -2-ilamino) propionico sustancialmente puro como inhibidor de la cinasa ikb. - Google Patents
Acido 2-{[2-(2- metilaminopirimidin -4-il)-1h- indol-5 -carbonil]amino}-3 -(fenilpiridin -2-ilamino) propionico sustancialmente puro como inhibidor de la cinasa ikb.Info
- Publication number
- MXPA06012870A MXPA06012870A MXPA06012870A MXPA06012870A MXPA06012870A MX PA06012870 A MXPA06012870 A MX PA06012870A MX PA06012870 A MXPA06012870 A MX PA06012870A MX PA06012870 A MXPA06012870 A MX PA06012870A MX PA06012870 A MXPA06012870 A MX PA06012870A
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- effective amount
- ikk
- inhibitors
- patient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57014604P | 2004-05-12 | 2004-05-12 | |
| PCT/US2005/016381 WO2005113544A1 (en) | 2004-05-12 | 2005-05-11 | Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06012870A true MXPA06012870A (es) | 2007-02-15 |
Family
ID=34969825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06012870A MXPA06012870A (es) | 2004-05-12 | 2005-05-11 | Acido 2-{[2-(2- metilaminopirimidin -4-il)-1h- indol-5 -carbonil]amino}-3 -(fenilpiridin -2-ilamino) propionico sustancialmente puro como inhibidor de la cinasa ikb. |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1747215A1 (pt) |
| JP (1) | JP2007537266A (pt) |
| KR (1) | KR20070011483A (pt) |
| CN (1) | CN1950359A (pt) |
| AR (1) | AR049274A1 (pt) |
| AU (1) | AU2005245834A1 (pt) |
| BR (1) | BRPI0511029A (pt) |
| CA (1) | CA2566213A1 (pt) |
| EC (1) | ECSP066992A (pt) |
| GT (1) | GT200500111A (pt) |
| IL (1) | IL178992A0 (pt) |
| MA (1) | MA28553B1 (pt) |
| MX (1) | MXPA06012870A (pt) |
| NO (1) | NO20065719L (pt) |
| PA (1) | PA8633101A1 (pt) |
| PE (1) | PE20060269A1 (pt) |
| RU (1) | RU2006143758A (pt) |
| SV (1) | SV2006002111A (pt) |
| TN (1) | TNSN06338A1 (pt) |
| TW (1) | TW200605881A (pt) |
| UY (1) | UY28897A1 (pt) |
| WO (1) | WO2005113544A1 (pt) |
| ZA (1) | ZA200608712B (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19951360A1 (de) | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
| DE102004033406A1 (de) | 2004-07-10 | 2006-02-16 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung der enantiomeren Formen von 2,3-Diaminopropionsäurederivaten |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| CN104491864A (zh) | 2008-04-21 | 2015-04-08 | 奥德纳米有限公司 | 用于治疗耳部疾病和病况的耳用调配物及方法 |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2011134140A1 (en) * | 2010-04-27 | 2011-11-03 | Hutchison Medipharma Limited | Pyrimidinyl indole compounds |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| AU2017290256A1 (en) | 2016-06-29 | 2019-01-17 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
| CN106588803A (zh) * | 2016-11-16 | 2017-04-26 | 西南科技大学 | 一种制备5‑乙酰基异噁唑的新方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10237722A1 (de) * | 2002-08-17 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase |
-
2005
- 2005-05-11 PE PE2005000524A patent/PE20060269A1/es not_active Application Discontinuation
- 2005-05-11 KR KR1020067023661A patent/KR20070011483A/ko not_active Application Discontinuation
- 2005-05-11 AU AU2005245834A patent/AU2005245834A1/en not_active Abandoned
- 2005-05-11 CA CA002566213A patent/CA2566213A1/en not_active Abandoned
- 2005-05-11 CN CNA200580015046XA patent/CN1950359A/zh active Pending
- 2005-05-11 RU RU2006143758/04A patent/RU2006143758A/ru not_active Application Discontinuation
- 2005-05-11 AR ARP050101914A patent/AR049274A1/es not_active Application Discontinuation
- 2005-05-11 EP EP05749733A patent/EP1747215A1/en not_active Withdrawn
- 2005-05-11 WO PCT/US2005/016381 patent/WO2005113544A1/en active Application Filing
- 2005-05-11 BR BRPI0511029-7A patent/BRPI0511029A/pt not_active IP Right Cessation
- 2005-05-11 JP JP2007513292A patent/JP2007537266A/ja not_active Abandoned
- 2005-05-11 GT GT200500111A patent/GT200500111A/es unknown
- 2005-05-11 MX MXPA06012870A patent/MXPA06012870A/es not_active Application Discontinuation
- 2005-05-12 UY UY28897A patent/UY28897A1/es unknown
- 2005-05-12 SV SV2005002111A patent/SV2006002111A/es not_active Application Discontinuation
- 2005-05-12 PA PA20058633101A patent/PA8633101A1/es unknown
- 2005-05-12 TW TW094115316A patent/TW200605881A/zh unknown
-
2006
- 2006-10-18 ZA ZA200608712A patent/ZA200608712B/en unknown
- 2006-10-18 TN TNP2006000338A patent/TNSN06338A1/en unknown
- 2006-10-27 MA MA29415A patent/MA28553B1/fr unknown
- 2006-11-01 IL IL178992A patent/IL178992A0/en unknown
- 2006-11-10 EC EC2006006992A patent/ECSP066992A/es unknown
- 2006-12-12 NO NO20065719A patent/NO20065719L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20060269A1 (es) | 2006-05-11 |
| RU2006143758A (ru) | 2008-06-27 |
| GT200500111A (es) | 2006-05-09 |
| TW200605881A (en) | 2006-02-16 |
| AR049274A1 (es) | 2006-07-12 |
| AU2005245834A1 (en) | 2005-12-01 |
| UY28897A1 (es) | 2005-12-30 |
| EP1747215A1 (en) | 2007-01-31 |
| ZA200608712B (en) | 2008-06-25 |
| BRPI0511029A (pt) | 2007-11-27 |
| TNSN06338A1 (en) | 2008-02-22 |
| WO2005113544A1 (en) | 2005-12-01 |
| JP2007537266A (ja) | 2007-12-20 |
| CN1950359A (zh) | 2007-04-18 |
| CA2566213A1 (en) | 2005-12-11 |
| NO20065719L (no) | 2006-12-12 |
| PA8633101A1 (es) | 2006-01-23 |
| IL178992A0 (en) | 2007-03-08 |
| MA28553B1 (fr) | 2007-04-03 |
| ECSP066992A (es) | 2006-12-29 |
| KR20070011483A (ko) | 2007-01-24 |
| SV2006002111A (es) | 2006-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA06012870A (es) | Acido 2-{[2-(2- metilaminopirimidin -4-il)-1h- indol-5 -carbonil]amino}-3 -(fenilpiridin -2-ilamino) propionico sustancialmente puro como inhibidor de la cinasa ikb. | |
| ES2461496T3 (es) | Inhibidores de cinasa MAP p38 | |
| ES2428917T3 (es) | Inhibidores de p38 MAP cinasa | |
| JP5855113B2 (ja) | Ｓ−ニトロソグルタチオン還元酵素阻害薬としての新規置換キノリン化合物 | |
| ES2302033T3 (es) | Derivados de quinozalina como inhibidores de la elastasa de los neurofilos y su utilizacion. | |
| ES2525756T3 (es) | Imidazo [1,2-a] piridinas como moduladores de JNK | |
| RU2661895C2 (ru) | Соединение сложного эфира гуанидинобензойной кислоты | |
| US20220185792A1 (en) | Prmt5 inhibitor compounds | |
| JP4393197B2 (ja) | 痴呆関連疾患、アルツハイマー病およびグリコーゲンシンターゼキナーゼ−３関連症状の治療におけるオキシインドール誘導体の使用 | |
| WO2021193756A1 (ja) | 新規ベンズイミダゾール誘導体 | |
| KR20140105459A (ko) | 키나아제 억제제 | |
| JP2018048143A (ja) | Ｋｃｎｑ２〜５チャネル活性化剤 | |
| WO2012002502A1 (ja) | ジヒドロピリミジノン誘導体およびその医薬用途 | |
| EP1030844A1 (en) | Compounds which inhibit tryptase activity | |
| US20070142417A1 (en) | Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor | |
| JP6441830B2 (ja) | カテプシンｃの置換２−アザ−ビシクロ［２．２．１］ヘプタン−３−カルボン酸（シアノ−メチル）−アミド阻害剤 | |
| CN115003381A (zh) | 化合物及其用于治疗α1-抗胰蛋白酶缺乏症的用途 | |
| US20200283396A1 (en) | Caspase inhibitors and methods of use thereof | |
| JPWO2003011812A1 (ja) | ヒト−β−トリプターゼ阻害活性を有する新規アミン誘導体およびそれを含有する医薬 | |
| US11447497B2 (en) | (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases | |
| JP2012512822A (ja) | ピリミジン−２−イルアミノ誘導体および炎症を治療するためのその使用 | |
| US8445529B2 (en) | Indole derivative having, carbamoyl group, ureido group and substituted oxy group | |
| CN115286583B (zh) | 一种含二苯基氨基嘧啶类化合物、制备及其作为HDACs酶抑制剂的应用 | |
| WO2006076318A1 (en) | Monopotassium salt of an ikb kinase inhibitor | |
| CN115210244A (zh) | 一种弹性蛋白酶抑制剂前药及其用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |